(Q46112762)
Statements
1 reference
LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose (English)
1 reference
David R Powell
1 reference
Melinda Smith
1 reference
Jennifer Greer
1 reference
Angela Harris
1 reference
Sharon Zhao
1 reference
Christopher DaCosta
1 reference
Faika Mseeh
1 reference
Melanie K Shadoan
1 reference
Arthur Sands
1 reference
Brian Zambrowicz
1 reference
Zhi-Ming Ding
1 reference
13 March 2013
1 reference
345
1 reference
2
1 reference
250-259
1 reference
Identifiers
1 reference
1 reference